Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Sanderson

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvantJ T Ulrich, W Cieplak, N J Paczkowski, et al.
Biopolymers|January 1, 1996
Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxinF Ni, K A Carpenter, D R Ripoll, et al.
The Journal of Biological Chemistry|June 16, 1995
The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, HckS D Briggs, S S Bryant, R Jove, et al.
British Journal of Pharmacology|October 12, 1999
Response-selective C5a agonists: differential effects on neutropenia and hypotension in the ratA J Short, N J Paczkowski, S M Vogen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Journal of Medicinal Chemistry|March 14, 1997
Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activityA M Finch, S M Vogen, S A Sherman, et al.
The Journal of Biological Chemistry|December 23, 1994
Differential effects of monoclonal antibodies on activating transcription factor-1 and cAMP response element binding protein interactions with DNAD J Orten, J M Strawhecker, S D Sanderson, et al.
Journal of Medicinal Chemistry|September 16, 1994
Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activitiesS D Sanderson, L Kirnarsky, S A Sherman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Conformationally biased analogs of human C5a mediate changes in vascular permeabilityR Kawatsu, S D Sanderson, I Blanco, et al.
Biochemical Pharmacology|May 30, 2001
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptorS A Cain, T M Woodruff, S M Taylor, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvantJ T Ulrich, W Cieplak, N J Paczkowski, et al.
Biopolymers|January 1, 1996
Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxinF Ni, K A Carpenter, D R Ripoll, et al.
The Journal of Biological Chemistry|June 16, 1995
The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, HckS D Briggs, S S Bryant, R Jove, et al.
British Journal of Pharmacology|October 12, 1999
Response-selective C5a agonists: differential effects on neutropenia and hypotension in the ratA J Short, N J Paczkowski, S M Vogen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Journal of Medicinal Chemistry|March 14, 1997
Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activityA M Finch, S M Vogen, S A Sherman, et al.
The Journal of Biological Chemistry|December 23, 1994
Differential effects of monoclonal antibodies on activating transcription factor-1 and cAMP response element binding protein interactions with DNAD J Orten, J M Strawhecker, S D Sanderson, et al.
Journal of Medicinal Chemistry|September 16, 1994
Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activitiesS D Sanderson, L Kirnarsky, S A Sherman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Conformationally biased analogs of human C5a mediate changes in vascular permeabilityR Kawatsu, S D Sanderson, I Blanco, et al.
Biochemical Pharmacology|May 30, 2001
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptorS A Cain, T M Woodruff, S M Taylor, et al.
Pageof 4